“…Recent studies suggest that secondary metabolites from Aquilaria species, which belong to the Thymelaeaceae family, have the potential to inhibit tumourigenesis by identifying the plant-derived compounds as anticancer agents (4). Various studies have revealed that the leaves of Aquilaria species have promising potential for agricultural and pharmaceutical industries due to their diverse biological activities such as antimicrobial (5), antifungal (6), antioxidant (5,7), antinociceptive (8), antiinflammatory (9-10), antidiabetic (11)(12) and anticancer (5,(13)(14) agents. Although some studies indicated that secondary metabolites of Aquilaria species could be used to treat cancer (7,15), there is still no scientific evidence on the effectiveness of A. malaccensis leaves as a treatment for breast cancer.…”